Drug General Information
Drug ID	D01JGB
Former ID	DNC010610
Drug Name	4-cyclooctyl-6-propylpyrimidine-2-carbonitrile
Drug Type	Small molecular drug
Indication	Discovery agent		Investigative	[530717]
Structure		Download 2D MOL 3D MOL
Formula	C16H23N3
Canonical SMILES	CCCC1=NC(=NC(=C1)C2CCCCCCC2)C#N
InChI	1S/C16H23N3/c1-2-8-14-11-15(19-16(12-17)18-14)13-9-6-4-3-5-7-10-13/h11,13H,2-10H2,1H3
InChIKey	AWOXPJKLDJGFMS-UHFFFAOYSA-N
PubChem Compound ID	46881498
Target and Pathway
Target(s)	Cathepsin K	Target Info	Inhibitor	[530717]
	Cathepsin S	Target Info	Inhibitor	[530717]
KEGG Pathway	Lysosome
	Osteoclast differentiation
	Toll-like receptor signaling pathway
	Rheumatoid arthritishsa04142:Lysosome
	Phagosome
	Antigen processing and presentation
	Tuberculosis
NetPath Pathway	TGF_beta_Receptor Signaling Pathway
	RANKL Signaling Pathway
	IL2 Signaling PathwayNetPath_22:Leptin Signaling Pathway
	IL2 Signaling Pathway
Reactome	Collagen degradation
	Degradation of the extracellular matrix
	Activation of Matrix Metalloproteinases
	Trafficking and processing of endosomal TLR
	MHC class II antigen presentationR-HSA-1236977:Endosomal/Vacuolar pathway
	Assembly of collagen fibrils and other multimeric structures
	MHC class II antigen presentation
WikiPathways	RANKL/RANK Signaling Pathway
	Osteoclast SignalingWP2796:Class I MHC mediated antigen processing & presentation
	Trafficking and processing of endosomal TLR
References
Ref 530717	Bioorg Med Chem Lett. 2010 Mar 1;20(5):1524-7. Epub 2010 Jan 25.Design and optimization of a series of novel 2-cyano-pyrimidines as cathepsin K inhibitors.
Ref 530717	Bioorg Med Chem Lett. 2010 Mar 1;20(5):1524-7. Epub 2010 Jan 25.Design and optimization of a series of novel 2-cyano-pyrimidines as cathepsin K inhibitors.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.